Clover Health Investments Corp, a U.S.-based health care company, specializes in offering Medicare Advantage health plans. The company provides a range of services, including hospital, medical, and private insurance, serving customers across the nation. Investors can trade Clover Health Investments Corp’s stock on the Nasdaq.
As of December 23, 2025, the company’s stock closed at $2.53, marking a decline from its 52-week high of $4.87, achieved on January 23, 2025. However, this closing price is slightly above the 52-week low of $2.12, recorded on August 7, 2025. Since the last earnings announcement, the stock has experienced an 11.6% drop, as reported in a news item dated December 4, 2025.
The company’s market capitalization stands at $1.3 billion USD. Despite its market presence, Clover Health Investments Corp has a negative price-to-earnings (P/E) ratio of -22.15, indicating that the company is currently not generating positive earnings. The price-to-book (P/B) ratio is 3.91, suggesting that the market values the company at nearly four times its book equity. These valuation metrics place Clover Health Investments Corp in a moderate valuation range compared to its peers, with its market price remaining below its historical peak but above its recent trough.
Clover Health Investments Corp continues to focus on its core offerings in the health care sector, providing Medicare Advantage plans and related services. For more information about their offerings, interested parties can visit their website at www.cloverhealth.com .
